A detailed history of Toroso Investments, LLC transactions in Incyte Corp stock. As of the latest transaction made, Toroso Investments, LLC holds 38,894 shares of INCY stock, worth $2.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
38,894
Previous 18,200 113.7%
Holding current value
$2.36 Million
Previous $1.14 Million 93.96%
% of portfolio
0.04%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $1.17 Million - $1.38 Million
20,694 Added 113.7%
38,894 $2.22 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $168,111 - $206,884
3,223 Added 21.52%
18,200 $1.14 Million
Q3 2023

Nov 15, 2023

BUY
$57.77 - $65.93 $21,779 - $24,855
377 Added 2.58%
14,977 $865,000
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $78,503 - $97,256
1,288 Added 9.68%
14,600 $909,000
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $878,085 - $1.08 Million
-12,503 Reduced 48.43%
13,312 $962,000
Q4 2022

Feb 15, 2023

BUY
$67.18 - $84.11 $897,524 - $1.12 Million
13,360 Added 107.27%
25,815 $2.07 Million
Q3 2022

Nov 23, 2022

BUY
$66.18 - $82.86 $90,203 - $112,938
1,363 Added 12.29%
12,455 $830,000
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $55,988 - $70,370
-846 Reduced 7.09%
11,092 $843,000
Q1 2022

May 20, 2022

BUY
$66.02 - $79.71 $270,021 - $326,013
4,090 Added 52.12%
11,938 $948,000
Q4 2021

Feb 16, 2022

BUY
$63.34 - $74.11 $177,922 - $208,174
2,809 Added 55.75%
7,848 $0
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $40,652 - $49,739
592 Added 13.31%
5,039 $347,000
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $76,435 - $83,766
957 Added 27.42%
4,447 $374,000
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $71,002 - $93,867
934 Added 36.54%
3,490 $284,000
Q4 2020

Feb 16, 2021

BUY
$80.74 - $97.7 $206,371 - $249,721
2,556 New
2,556 $222,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.